RhumbLine Advisers
APYX icon

RhumbLine Advisers’s Apyx Medical APYX Stock Holding History

RhumbLine Advisers’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,284
Closed -$1.72K – 4202
2024
Q2 		$1.72K Hold
1,284
– – ﹤0.01% 4198
2024
Q1 		$1.75K Hold
1,284
– – ﹤0.01% 4099
2023
Q4 		$3.36K Hold
1,284
– – ﹤0.01% 4041
2023
Q3 		$4.11K Hold
1,284
– – ﹤0.01% 4015
2023
Q2 		$6.46K Buy
+1,284
New +$6.5K ﹤0.01% 4038
2022
Q2 		– Sell
-27,228
Closed -$178K – 3100
2022
Q1 		$178K Buy
27,228
+3,769
+16% +$37.1K ﹤0.01% 2784
2021
Q4 		$301K Sell
23,459
-347
-1% -$4.85K ﹤0.01% 2702
2021
Q3 		$330K Buy
23,806
+1,714
+8% +$18K ﹤0.01% 2729
2021
Q2 		$228K Sell
22,092
-17,970
-45% -$178K ﹤0.01% 2889
2021
Q1 		$387K Sell
40,062
-1,905
-5% -$19.1K ﹤0.01% 2601
2020
Q4 		$302K Buy
41,967
+6,594
+19% +$43.7K ﹤0.01% 2657
2020
Q3 		$167K Sell
35,373
-8,254
-19% -$40.9K ﹤0.01% 2743
2020
Q2 		$242K Buy
43,627
+2,785
+7% +$11.6K ﹤0.01% 2679
2020
Q1 		$147K Buy
40,842
+2,930
+8% +$19.7K ﹤0.01% 2683
2019
Q4 		$321K Buy
37,912
+566
+2% +$4.09K ﹤0.01% 2558
2019
Q3 		$253K Buy
37,346
+6,634
+22% +$47.1K ﹤0.01% 2656
2019
Q2 		$206K Buy
+30,712
New +$167K ﹤0.01% 2779

Other funds holding APYX

ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

RhumbLine Advisers's APYX Position: Q3 2024 in Review

RhumbLine Advisers sold out of Apyx Medical (APYX) in Q3 2024, closing a stake of 1,284 shares — an estimated $1.72K sold.

RhumbLine Advisers first reported a position in APYX in Q2 2019 and held it in 17 quarters. The position peaked at $387K in Q1 2021. 45 funds tracked by Wall St. Rank hold APYX as of Q3 2024.

  • RhumbLine Advisers reported no remaining Apyx Medical position as of Q3 2024 after selling out during the quarter.
  • RhumbLine Advisers sold 1,284 Apyx Medical shares in Q3 2024, an estimated $1.72K.
  • RhumbLine Advisers first reported a position in Apyx Medical in Q2 2019 and held it in 17 quarters.
  • RhumbLine Advisers's Apyx Medical position peaked at $387K in Q1 2021.
  • 45 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2024.

Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.